FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056912245> ?p ?o ?g. }

• W2056912245 endingPage "222" @default.
• W2056912245 startingPage "216" @default.
• W2056912245 abstract "<b><i>Purpose:</i></b> To investigate the outcome of intravitreal ranibizumab and/or dexamethasone implant treatment for treatment of macular edema (ME) secondary to central or branch retinal vein occlusion (CRVO or BRVO) in a clinical setting. <b><i>Methods:</i></b> Retrospective analysis of consecutive patients followed for at least 6 months. Data recorded included the type of occlusion, initial and final visual acuity, and number of injections. <b><i>Results:</i></b> Sixty-five patients were included, 26 had CRVO and 39 BRVO. Mean (±SD) follow-up duration was 16 (±7.7) months. Twenty-four (36.9%) patients received ranibizumab in monotherapy, 19 patients (29.3%) dexamethasone in monotherapy, and 22 patients (33.8%) received successively both treatments. In dexamethasone-treated patients, mean (±SD) visual acuity gain was 5.8 ± 10.7 letters for BRVO and 16.8 ± 15.6 letters for CRVO. In ranibizumab-treated patients, mean (±SD) visual acuity gain was 9.2 ± 10 letters for BRVO and 18.2 ± 20.5 letters for CRVO. <b><i>Conclusion:</i></b> Both intravitreal ranibizumab and dexamethasone intravitreal implant could be used as first-line therapy for patients with ME secondary to retinal vein occlusion." @default.
• W2056912245 created "2016-06-24" @default.
• W2056912245 creator A5004582783 @default.
• W2056912245 creator A5005958279 @default.
• W2056912245 creator A5013879260 @default.
• W2056912245 creator A5025630073 @default.
• W2056912245 creator A5053183041 @default.
• W2056912245 creator A5056792554 @default.
• W2056912245 creator A5073889285 @default.
• W2056912245 creator A5077709110 @default.
• W2056912245 creator A5079830274 @default.
• W2056912245 date "2014-01-01" @default.
• W2056912245 modified "2023-10-01" @default.
• W2056912245 title "Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion" @default.
• W2056912245 cites W1565832645 @default.
• W2056912245 cites W1898187276 @default.
• W2056912245 cites W1967175861 @default.
• W2056912245 cites W1970087369 @default.
• W2056912245 cites W1971532704 @default.
• W2056912245 cites W1972105764 @default.
• W2056912245 cites W1972614420 @default.
• W2056912245 cites W1975265153 @default.
• W2056912245 cites W1977995451 @default.
• W2056912245 cites W1991049779 @default.
• W2056912245 cites W1991903474 @default.
• W2056912245 cites W2000236282 @default.
• W2056912245 cites W2017240503 @default.
• W2056912245 cites W2029715222 @default.
• W2056912245 cites W2031329755 @default.
• W2056912245 cites W2034056754 @default.
• W2056912245 cites W2038724655 @default.
• W2056912245 cites W2044968030 @default.
• W2056912245 cites W2052204551 @default.
• W2056912245 cites W2057093974 @default.
• W2056912245 cites W2060668488 @default.
• W2056912245 cites W2061916858 @default.
• W2056912245 cites W2066940804 @default.
• W2056912245 cites W2068100937 @default.
• W2056912245 cites W2068779395 @default.
• W2056912245 cites W2068976954 @default.
• W2056912245 cites W2075780935 @default.
• W2056912245 cites W2078985232 @default.
• W2056912245 cites W2079693408 @default.
• W2056912245 cites W2082208163 @default.
• W2056912245 cites W2093446675 @default.
• W2056912245 cites W2128701654 @default.
• W2056912245 cites W2133950656 @default.
• W2056912245 cites W2140126320 @default.
• W2056912245 cites W2142651474 @default.
• W2056912245 cites W2144771657 @default.
• W2056912245 cites W2169265493 @default.
• W2056912245 cites W2324588265 @default.
• W2056912245 cites W2767447900 @default.
• W2056912245 cites W4229823998 @default.
• W2056912245 cites W4237391818 @default.
• W2056912245 cites W2132173474 @default.
• W2056912245 doi "https://doi.org/10.1159/000365639" @default.
• W2056912245 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25413000" @default.
• W2056912245 hasPublicationYear "2014" @default.
• W2056912245 type Work @default.
• W2056912245 sameAs 2056912245 @default.
• W2056912245 citedByCount "13" @default.
• W2056912245 countsByYear W20569122452015 @default.
• W2056912245 countsByYear W20569122452016 @default.
• W2056912245 countsByYear W20569122452017 @default.
• W2056912245 countsByYear W20569122452018 @default.
• W2056912245 countsByYear W20569122452020 @default.
• W2056912245 countsByYear W20569122452021 @default.
• W2056912245 crossrefType "journal-article" @default.
• W2056912245 hasAuthorship W2056912245A5004582783 @default.
• W2056912245 hasAuthorship W2056912245A5005958279 @default.
• W2056912245 hasAuthorship W2056912245A5013879260 @default.
• W2056912245 hasAuthorship W2056912245A5025630073 @default.
• W2056912245 hasAuthorship W2056912245A5053183041 @default.
• W2056912245 hasAuthorship W2056912245A5056792554 @default.
• W2056912245 hasAuthorship W2056912245A5073889285 @default.
• W2056912245 hasAuthorship W2056912245A5077709110 @default.
• W2056912245 hasAuthorship W2056912245A5079830274 @default.
• W2056912245 hasConcept C118487528 @default.
• W2056912245 hasConcept C126322002 @default.
• W2056912245 hasConcept C141071460 @default.
• W2056912245 hasConcept C2776694085 @default.
• W2056912245 hasConcept C2777802072 @default.
• W2056912245 hasConcept C2778257484 @default.
• W2056912245 hasConcept C2778844676 @default.
• W2056912245 hasConcept C2780261187 @default.
• W2056912245 hasConcept C2780347916 @default.
• W2056912245 hasConcept C2780401358 @default.
• W2056912245 hasConcept C2781100027 @default.
• W2056912245 hasConcept C2781411149 @default.
• W2056912245 hasConcept C2908732032 @default.
• W2056912245 hasConcept C71924100 @default.
• W2056912245 hasConceptScore W2056912245C118487528 @default.
• W2056912245 hasConceptScore W2056912245C126322002 @default.
• W2056912245 hasConceptScore W2056912245C141071460 @default.
• W2056912245 hasConceptScore W2056912245C2776694085 @default.
• W2056912245 hasConceptScore W2056912245C2777802072 @default.
• W2056912245 hasConceptScore W2056912245C2778257484 @default.

• next